Literature DB >> 31926352

Mycobacterium chelonae, an 'atypical' cause of an LVAD driveline infection.

Stefan Roest1, Hannelore I Bax2, Nelianne J Verkaik3, Jasper J Brugts1, Alina A Constantinescu1, Chantal C de Bakker1, Ozcan Birim4, Kadir Caliskan1, Olivier C Manintveld5.   

Abstract

We describe the first patient with a left ventricular assist device (LVAD) driveline infection caused by Mycobacterium chelonae presenting with persistent infection despite conventional antibiotics. Treatment was successful with surgical debridement, driveline exit relocation, and a 4-month period of antibiotics. In the case of a culture-negative LVAD driveline infection, non-tuberculous mycobacteria should be considered. This case illustrates that multidisciplinary collaboration is essential in providing optimal care for LVAD patients.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Driveline infection; Left ventricular assist device; Mycobacterium chelonae

Year:  2020        PMID: 31926352     DOI: 10.1016/j.ijid.2020.01.002

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  3 in total

Review 1.  Nontuberculous Mycobacterial Infections Associated With Left Ventricular Assist Devices in 3 Patients.

Authors:  Manavotam Singh; Mrinalini Krishnan; Maria Elena Ruiz; Farooq H Sheikh
Journal:  Tex Heart Inst J       Date:  2022-07-01

2.  Mycobacterium abscessus Infection in Left Ventricular Assist Device (LVAD): A Case Series.

Authors:  Jarelys M Hernandez; Mallorie Huff; Zola Nlandu; Bhavesh Vekariya; Jeniffer Torres
Journal:  Cureus       Date:  2021-06-17

3.  Cardiovascular device infections due to rapidly growing Mycobacteria: A review of cases at a tertiary care hospital.

Authors:  Isin Yagmur Comba; Supavit Chesdachai; Hussam Tabaja; Maryam Mahmood; Sharon Deml; Nancy L Wengenack; John W Wilson
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2022-01-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.